These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23542114)

  • 1. Arsenic trioxide depletes cancer stem-like cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of Notch pathway.
    Wu J; Ji Z; Liu H; Liu Y; Han D; Shi C; Shi C; Wang C; Yang G; Chen X; Shen C; Li H; Bi Y; Zhang D; Zhao S
    Toxicol Lett; 2013 Jun; 220(1):61-9. PubMed ID: 23542114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
    Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
    Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
    Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
    Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of cancer stem-like cells and potentiation of temozolomide sensitivity by Honokiol in glioblastoma multiforme cells.
    Lai IC; Shih PH; Yao CJ; Yeh CT; Wang-Peng J; Lui TN; Chuang SE; Hu TS; Lai TY; Lai GM
    PLoS One; 2015; 10(3):e0114830. PubMed ID: 25763821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.
    Fan X; Khaki L; Zhu TS; Soules ME; Talsma CE; Gul N; Koh C; Zhang J; Li YM; Maciaczyk J; Nikkhah G; Dimeco F; Piccirillo S; Vescovi AL; Eberhart CG
    Stem Cells; 2010 Jan; 28(1):5-16. PubMed ID: 19904829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic trioxide-mediated Notch pathway inhibition depletes the cancer stem-like cell population in gliomas.
    Zhen Y; Zhao S; Li Q; Li Y; Kawamoto K
    Cancer Lett; 2010 Jun; 292(1):64-72. PubMed ID: 19962820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells.
    Spina R; Voss DM; Asnaghi L; Sloan A; Bar EE
    Oncotarget; 2016 Jan; 7(1):459-72. PubMed ID: 26575950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
    Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
    Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance.
    Schreck KC; Taylor P; Marchionni L; Gopalakrishnan V; Bar EE; Gaiano N; Eberhart CG
    Clin Cancer Res; 2010 Dec; 16(24):6060-70. PubMed ID: 21169257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch signal activates hypoxia pathway through HES1-dependent SRC/signal transducers and activators of transcription 3 pathway.
    Lee JH; Suk J; Park J; Kim SB; Kwak SS; Kim JW; Lee CH; Byun B; Ahn JK; Joe CO
    Mol Cancer Res; 2009 Oct; 7(10):1663-71. PubMed ID: 19808903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide inhibits Hedgehog, Notch and stem cell properties in glioblastoma neurospheres.
    Ding D; Lim KS; Eberhart CG
    Acta Neuropathol Commun; 2014 Mar; 2():31. PubMed ID: 24685274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
    Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
    Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide sensitizes glioblastoma to a myc inhibitor.
    Yoshimura Y; Shiino A; Muraki K; Fukami T; Yamada S; Satow T; Fukuda M; Saiki M; Hojo M; Miyamoto S; Onishi N; Saya H; Inubushi T; Nozaki K; Tanigaki K
    PLoS One; 2015; 10(6):e0128288. PubMed ID: 26038891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of arsenic trioxide and all-trans retinoic acid on p53 R273H-codon mutant glioblastoma.
    Karsy M; Albert L; Murali R; Jhanwar-Uniyal M
    Tumour Biol; 2014 May; 35(5):4567-80. PubMed ID: 24399651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic Trioxide Induces Retinoic Acid-Related Orphan Receptor Beta and Blocks the WNT Pathway to Inhibit Stemness in Glioblastoma.
    Ding D; Gao K; Zhang X; Wang H
    Tohoku J Exp Med; 2024 Sep; 263(3):199-210. PubMed ID: 38797699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells.
    Sherry MM; Reeves A; Wu JK; Cochran BH
    Stem Cells; 2009 Oct; 27(10):2383-92. PubMed ID: 19658181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures.
    Kristoffersen K; Villingshøj M; Poulsen HS; Stockhausen MT
    Cancer Biol Ther; 2013 Jul; 14(7):625-37. PubMed ID: 23792644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma stem cells: a new target for metformin and arsenic trioxide.
    Carmignani M; Volpe AR; Aldea M; Soritau O; Irimie A; Florian IS; Tomuleasa C; Baritchii A; Petrushev B; Crisan G; Valle G
    J Biol Regul Homeost Agents; 2014; 28(1):1-15. PubMed ID: 24750786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.